Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML
ClinicalTrials.gov study NCT02306291. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)
ClinicalTrials.gov study NCT00779480. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML
ClinicalTrials.gov study NCT04248595. IPD Sharing: NO. Countries: 1. Publications: 1.
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
ClinicalTrials.gov study NCT00111345. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation
ClinicalTrials.gov study NCT02984995. IPD Sharing: YES. Countries: 1. Publications: 0.
IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML
ClinicalTrials.gov study NCT04372433. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)
ClinicalTrials.gov study NCT00479232. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Imetelstat Combinations in Relapsed AML
ClinicalTrials.gov study NCT07320235. IPD Sharing: NO. Countries: 1. Publications: 21.
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
ClinicalTrials.gov study NCT06529250. IPD Sharing: NO. Countries: 1. Publications: 3.
FLYSYN in MRD Positive AML
ClinicalTrials.gov study NCT02789254. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT03121014. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5
ClinicalTrials.gov study NCT00761449. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00495287. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02641002. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del
ClinicalTrials.gov study NCT00885508. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT
ClinicalTrials.gov study NCT04476199. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDS
ClinicalTrials.gov study NCT04477291. IPD Sharing: NO. Countries: 1. Publications: 2.
DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
ClinicalTrials.gov study NCT03110354. IPD Sharing: YES. Countries: 1. Publications: 0.
IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT
ClinicalTrials.gov study NCT02671708. IPD Sharing: YES. Countries: 1. Publications: 1.
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
ClinicalTrials.gov study NCT03188874. IPD Sharing: NO. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.